Khiron Life Sciences Corp. announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced total revenue was CAD 1.928 million compared to CAD 2.773 million a year ago. Net loss was CAD 6.714 million compared to CAD 10.621 million a year ago. Basic loss per share from continuing operations was CAD 0.06 compared to CAD 0.09 a year ago. For the nine months, total revenue was CAD 5.499 million compared to CAD 7.071 million a year ago. Net loss was CAD 21.664 million compared to CAD 28.142 million a year ago. Basic loss per share from continuing operations was CAD 0.19 compared to CAD 0.29 a year ago.